Hyperglycemia is known to aggravate ischemic brain damage. The present experiments were undertaken to explore whether hyperglycemia caused by streptozotocin-induced diabetes exacerbates brain damage following transient brain ischemia as it does in animals acutely infused with glucose. Experimental diabetes was induced by injection of streptozotocin in rats which were subjected to 10 min of forebrain ischemia either 1 week (1-wk) or 4 weeks (4-wk) after the induction of diabetes. Normoglycemic rats exposed to the same duration of ischemia and sham-operated diabetic rats served as controls. The animals underwent evaluation of clinical outcome and histopathological analysis of brain damage. Postischemic seizures developed in 35.3 and 42.1% of 1-wk and 4-wk diabetic hyperglycemic animals, respectively. The incidence of seizure was not different between the two groups. None of the diabetic animals with plasma glucose concentrations below 12 mM exhibited seizure activity. The extent and distribution of brain damage were similar between 1-and 4-wk diabetic animals. In the CA1 and in the subicular regions of hippocampus, both diabetic hyperglycemic and normoglycemic animals showed 70-80% cell death. Diabetic hyperglycemic animals had more severe neuronal necrosis in the parietal cortex than normoglycemic animals. In diabetic hyperglycemic animals, neuronal damage involved additional brain structures, e.g., cingulate cortex, thalamus nuclei, substantia nigra, pars reticulata, and the hippocampal CA3 sector, i.e., structures in which neurons were not affected in normoglycemic ischemic subjects at this duration of ischemia. These findings demonstrate that diabetic hyperglycemic animals frequently develop postischemic seizures and that streptozotocin-induced hyperglycemia results in exacerbated postischemic brain damage of the same density and distribution as in acutely glucose-infused animals. 1998 Academic Press
INTRODUCTION
Many studies have identified diabetes as an independent and significant risk factor for stroke (Abbott et al., 1987; Barrett-Connor & Khaw, 1988 ). There is a greater incidence of cerebral ischemic insults and higher risk of death from stroke in persons with diabetes mellitus than in those who do not have the disease (Pulsinelli et al., 1983; Bell, 1994; Tuomilehto et al., 1996) . Preischemic hyperglycemia aggravates brain damage caused by transient global or forebrain ischemia (for reviews, see Siesjö , 1988; Siesjö et al., 1993 Siesjö et al., , 1996 . The cardinal features of such accentuated damage are rapidly evolving neuronal necrosis, gross edema, and postischemic seizures. The question arises whether hyperglycemia of longer duration, as is observed in diabetes, will exacerbate ischemic brain damage in the same way as observed in glucose-infused animals. This question is relevant to the clinical situation because hyperglycemia is a characteristic feature in poorly regulated diabetes and the incidence of cerebral ischemic insults in patients with diabetes is greater than that in nondiabetic patients.
Available results do not give unequivocal information on this matter. Warner et al. (1992) , studying rats with 5-7 days of streptozotocin-induced diabetes, reported that such rats had damage to the CA1 sector of the hippocampus and to the substantia nigra, pars
